Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis

Soheil Hassanipour; Hamed Delam; Morteza Arab-Zozani; Elham Abdzadeh; Seyyed Ali Hosseini; Hossein-Ali Nikbakht; Mahdi Malakoutikhah; Mohammad Taghi Ashoobi; Mohammad Fathalipour; Hamid Salehiniya; Shirin Riahi

doi:10.5334/aogh.2607

Abstract

Background: Prostate cancer is one of the most common health issues among men, especially older men. In recent years, incidences of prostate cancer is increasing.

Objective: The aim of this study was to provide a comprehensive estimate of the survival of prostate cancer in Asian countries.

Methods: We searched five international databases including Medline/PubMed, Scopus, Embase, Web of Knowledge and ProQuest until June 1, 2018. The Newcastle-Ottawa Quality Assessment was used to evaluate the quality of selected papers. The review protocol was registered in PROSPERO (CRD42019117044).

Results: A total of 714 titles were retrieved. Thirty-seven studies met the inclusion criteria. Based on the random-effect model one-year, five-year and ten-year survival rate of prostate cancer were 81% (95% CI 77.8–84.2), 61.9% (95% CI 59.5–64.3) and 36.2% (95% CI 9.2–63.2) respectively. Survival rates based on HDI level for five-year were 30.07, 43.43 and 70.84 percent for medium, high and very high levels, respectively.

Conclusion: According to the results of our study, the prostate cancer survival rate in Asian countries is relatively lower than in Europe and North America.

References

Siegel RL, Miller KD and Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1): 7–30. DOI: 10.3322/caac.21442
Open DOI Search in Google Scholar Back to article
Hassanipour-Azgomi S, Mohammadian-Hafshejani A, Ghoncheh M, Towhidi F, Jamehshorani S and Salehiniya H. Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide. Prostate Int. 2016; 4(3): 118–124. DOI: 10.1016/j.prnil.2016.07.001
Open DOI Search in Google Scholar Back to article
Bashir MN. Epidemiology of Prostate Cancer. Asian Pac J Cancer Prev. 2015; 16(13): 5137–5141. DOI: 10.7314/APJCP.2015.16.13.5137
Open DOI Search in Google Scholar Back to article
Brawley OW. Prostate cancer epidemiology in the United States. World J Urol. 2012; 30(2): 195–200. DOI: 10.1007/s00345-012-0824-2
Open DOI Search in Google Scholar Back to article
McDavid K, Lee J, Fulton JP, Tonita J and Thompson TD. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep. 2004; 119(2): 174–186. DOI: 10.1177/003335490411900211
Open DOI Search in Google Scholar Back to article
Kelly SP, Rosenberg PS, Anderson WF, et al. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. Eur Urol. 2017; 71(2): 195–201. DOI: 10.1016/j.eururo.2016.05.011
Open DOI Search in Google Scholar Back to article
Zhang K, Bangma CH and Roobol MJ. Prostate cancer screening in Europe and Asia. Asian J Urol. 2017; 4(2): 86–95. DOI: 10.1016/j.ajur.2016.08.010
Open DOI Search in Google Scholar Back to article
Zhou CK, Check DP, Lortet-Tieulent J, et al. Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int J Cancer. 2016; 138(6): 1388–1400. DOI: 10.1002/ijc.29894
Open DOI Search in Google Scholar Back to article
Carducci MA, Cetin K, Markus R and Fryzek JP. Time trends in the epidemiology of newly diagnosed stage IV prostate cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program (1988–2003). Journal of Clinical Oncology. 2008; 26(15_suppl): 5059. DOI: 10.1200/jco.2008.26.15_suppl.5059
Open DOI Search in Google Scholar Back to article
Salehiniya H, Pakzad R, Hassanipour S and Mohammadian M. The incidence and mortality of thyroid cancer and its relationship with HDI in the world. World Cancer Research Journal. 2018; 5(2): 1–6.
Search in Google Scholar Back to article
Chornokur G, Dalton K, Borysova ME and Kumar NB. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate. 2011; 71(9): 985–997. DOI: 10.1002/pros.21314
Open DOI Search in Google Scholar Back to article
Hajjar RR, Atli T, Al-Mandhari Z, Oudrhiri M, Balducci L and Silbermann M. Prevalence of aging population in the Middle East and its implications on cancer incidence and care. Ann Oncol. 2013; 24(Suppl 7): vii11–24. DOI: 10.1093/annonc/mdt268
Open DOI Search in Google Scholar Back to article
Gu X, Zheng R, Xia C, et al. Interactions between life expectancy and the incidence and mortality rates of cancer in China: A population-based cluster analysis. Cancer Commun (Lond). 2018; 38(1): 44. DOI: 10.1186/s40880-018-0308-x
Open DOI Search in Google Scholar Back to article
Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, Pakzad I and Salehiniya H. The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int. 2015; 3(4): 135–140. DOI: 10.1016/j.prnil.2015.09.001
Open DOI Search in Google Scholar Back to article
Baade PD, Youlden DR, Cramb SM, Dunn J and Gardiner RA. Epidemiology of prostate cancer in the Asia-Pacific region. Prostate International. 2013; 1(2): 47–58. DOI: 10.12954/PI.12014
Open DOI Search in Google Scholar Back to article
Cullen J, Elsamanoudi S, Brassell SA, et al. The burden of prostate cancer in Asian nations. J Carcinog. 2012; 11: 7. DOI: 10.4103/1477-3163.94025
Open DOI Search in Google Scholar Back to article
Chen SL, Wang SC, Ho CJ, et al. Prostate cancer mortality-to-incidence ratios are associated with cancer care disparities in 35 countries. Sci Rep. 2017; 7: 40003. DOI: 10.1038/srep40003
Open DOI Search in Google Scholar Back to article
Chen JG, Zhu J, Zhang YH and Lu JH. Cancer survival in Qidong, China, 1992–2000. IARC Sci Publ. 2011; 162: 43–53.
Search in Google Scholar Back to article
Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH and Lee JS. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014; 46(2): 109–123. DOI: 10.4143/crt.2014.46.2.109
Open DOI Search in Google Scholar Back to article
Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011; 43(1): 1–11. DOI: 10.4143/crt.2011.43.1.1
Open DOI Search in Google Scholar Back to article
Jung KW, Won YJ, Oh CM, et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014. Cancer Res Treat. 2017; 49(2): 292–305. DOI: 10.4143/crt.2017.118
Open DOI Search in Google Scholar Back to article
Zahir ST, Nazemian MR, Zand S and Zare S. Survival of patients with prostate cancer in Yazd, Iran. Asian Pac J Cancer Prev. 2014; 15(2): 883–886. DOI: 10.7314/APJCP.2014.15.2.883
Open DOI Search in Google Scholar Back to article
Wang F, Feng J, Chen P, et al. Probiotics in Helicobacter pylori eradication therapy: Systematic review and network meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 2017; 41(4): 466–475. DOI: 10.1016/j.clinre.2017.04.004
Open DOI Search in Google Scholar Back to article
Xu H, Zhang LM, Liu J, Ding GX, Ding Q and Jiang HW. The association between overall survival of prostate cancer patients and hypertension, hyperglycemia, and overweight in Southern China: A prospective cohort study. J Cancer Res Clin Oncol. 2013; 139(6): 943–951. DOI: 10.1007/s00432-013-1407-3
Open DOI Search in Google Scholar Back to article
Kelloff GJ, Choyke P and Coffey DS. Prostate Cancer Imaging Working G. Challenges in clinical prostate cancer: Role of imaging. AJR Am J Roentgenol. 2009; 192(6): 1455–1470. DOI: 10.2214/AJR.09.2579
Open DOI Search in Google Scholar Back to article
Myint Z, Huang B, Chen Q and Wang P. Epidemiology and survival disparities of prostate cancer in Appalachian Kentucky. Journal of Clinical Oncology. 2018; 36(6_suppl): 292–292. DOI: 10.1200/JCO.2018.36.6_suppl.292
Open DOI Search in Google Scholar Back to article
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4(1): 1. DOI: 10.1186/2046-4053-4-1
Open DOI Search in Google Scholar Back to article
Penson DF, Krishnaswami S, Jules A, Seroogy JC and McPheeters ML. Evaluation and treatment of cryptorchidism. 2012.
Search in Google Scholar Back to article
Human Development Reports. 2018. http://hdr.undp.org/en/2018-update.
Search in Google Scholar Back to article
Jung KW, Yim SH, Kong HJ, et al. Cancer survival in Korea 1993–2002: A population-based study. J Korean Med Sci. 2007; 22(Suppl): S5–S10. DOI: 10.3346/jkms.2007.22.S.S5
Open DOI Search in Google Scholar Back to article
Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012; 44(1): 11–24. DOI: 10.4143/crt.2012.44.1.11
Open DOI Search in Google Scholar Back to article
Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG and Lee JS. Cancer statistics in Korea: Incidence, mortality, survival and prevalence in 2010. Cancer Res Treat. 2013; 45(1): 1–14. DOI: 10.4143/crt.2013.45.1.1
Open DOI Search in Google Scholar Back to article
Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47(2): 127–141. DOI: 10.4143/crt.2015.060
Open DOI Search in Google Scholar Back to article
Oh CM, Won YJ, Jung KW, et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016; 48(2): 436–450. DOI: 10.4143/crt.2016.089
Open DOI Search in Google Scholar Back to article
Jung KW, Won YJ, Kong HJ, Lee ES and Community of Population-Based Regional Cancer R. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018; 50(2): 303–316. DOI: 10.4143/crt.2018.143
Open DOI Search in Google Scholar Back to article
Jin F, Xiang YB and Gao YT. Cancer survival in Shanghai, People’s Republic of China. IARC Sci Publ. 1998; 145: 37–50.
Search in Google Scholar Back to article
Xishan H, Chen K, Min H, Shufen D and Jifang W. Cancer survival in Tianjin, China, 1991–1999. IARC Sci Publ. 2011; 162: 69–84.
Search in Google Scholar Back to article
Chen JG, Chen HZ, Zhu J, et al. Cancer survival in patients from a hospital-based cancer registry, China. J Cancer. 2018; 9(5): 851–860. DOI: 10.7150/jca.23039
Open DOI Search in Google Scholar Back to article
Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–15: A pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018; 6(5): e555–e567. DOI: 10.1016/S2214-109X(18)30127-X
Open DOI Search in Google Scholar Back to article
Sato Y. Survival Trends of Patients Treated at the National Cancer Center Hospital, Japan, from 1962 to 1994. Japanese Journal of Clinical Oncology. 2002; 32(5): 181–186. DOI: 10.1093/jjco/hyf037
Open DOI Search in Google Scholar Back to article
Tsukuma H, Ajiki W, Ioka A, Oshima A and Research Group of Population-Based Cancer Registries of J. Survival of cancer patients diagnosed between 1993 and 1996: A collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 2006; 36(9): 602–607. DOI: 10.1093/jjco/hyl068
Open DOI Search in Google Scholar Back to article
Matsuda T, Ajiki W, Marugame T, et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: A chronological and international comparative study. Jpn J Clin Oncol. 2011; 41(1): 40–51. DOI: 10.1093/jjco/hyq167
Open DOI Search in Google Scholar Back to article
Ito Y, Nakayama T, Miyashiro I, Ioka A and Tsukuma H. Conditional survival for longer-term survivors from 2000–2004 using population-based cancer registry data in Osaka, Japan. BMC Cancer. 2013; 13: 304. DOI: 10.1186/1471-2407-13-304
Open DOI Search in Google Scholar Back to article
Ito Y, Miyashiro I, Ito H, et al. Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci. 2014; 105(11): 1480–1486. DOI: 10.1111/cas.12525
Open DOI Search in Google Scholar Back to article
Jayalekshmi P, Gangadharan P and Sebastian P. Cancer survival in Karunagappally, India, 1991–1997. IARC Sci Publ. 2011; 162: 125–132.
Search in Google Scholar Back to article
Yeole BB, Kurkure AP and Sunny L. Cancer survival in Mumbai (Bombay), India, 1992–1999. IARC Sci Publ. 2011; 162: 133–142.
Search in Google Scholar Back to article
Balasubramaniam G, Talole S, Mahantshetty U, Saoba S and Shrivastava S. Prostate cancer: a hospital-based survival study from Mumbai, India. Asian Pac J Cancer Prev. 2013; 14(4): 2595–2598. DOI: 10.7314/APJCP.2013.14.4.2595
Open DOI Search in Google Scholar Back to article
Takiar R, Krishnan SK and Shah VP. A model approach to calculate cancer prevalence from 5 years survival data for selected cancer sites in India—Part II. Asian Pac J Cancer Prev. 2014; 15(14): 5681–5684. DOI: 10.7314/APJCP.2014.15.14.5681
Open DOI Search in Google Scholar Back to article
Martin N, Srisukho S, Kunpradist O and Suttajit M. Cancer survival in Chiang Mai, Thailand. IARC Sci Publ. 1998; 145: 109–121.
Search in Google Scholar Back to article
Martin N, Pongnikorn S, Patel N and Daoprasert K. Cancer survival in Lampang, Thailand, 1990–2000. IARC Sci Publ. 2011; 162: 217–226.
Search in Google Scholar Back to article
Sriplung H and Prechavittayakul P. Cancer survival in Songkhla, Thailand, 1990–1999. IARC Sci Publ. 2011; 162: 227–235.
Search in Google Scholar Back to article
Sumitsawan Y, Srisukho S, Sastraruji A, Chaisaengkhum U, Maneesai P and Waisri N. Cancer survival in Chiang Mai, Thailand, 1993–1997. IARC Sci Publ. 2011; 162: 199–209.
Search in Google Scholar Back to article
Lim GH, Wong CS, Chow KY, Bhalla V and Chia KS. Trends in long-term cancer survival in Singapore: 1968–2002. Ann Acad Med Singapore. 2009; 38(2): 99–105.
Search in Google Scholar Back to article
Chia KS. Cancer survival in Singapore, 1993–1997. IARC Sci Publ. 2011; 162: 183–198.
Search in Google Scholar Back to article
Chang CM, Huang KY, Hsu TW, et al. Multivariate analyses to assess the effects of surgeon and hospital volume on cancer survival rates: A nationwide population-based study in Taiwan. PLoS One. 2012; 7(7): e40590. DOI: 10.1371/journal.pone.0040590
Open DOI Search in Google Scholar Back to article
Chien LH, Tseng TJ, Tsai FY, et al. Patterns of age-specific socioeconomic inequalities in net survival for common cancers in Taiwan, a country with universal health coverage. Cancer Epidemiol. 2018; 53: 42–48. DOI: 10.1016/j.canep.2018.01.006
Open DOI Search in Google Scholar Back to article
Law SC and Mang OW. Cancer survival in Hong Kong SAR, China, 1996–2001. IARC Sci Publ. 2011; 162: 33–41.
Search in Google Scholar Back to article
Esteban D, Ngelangel C, Lacaya L, Robles E and Monson M. Cancer survival in Rizal, Philippines. IARC Sci Publ. 1998; 145: 101–108.
Search in Google Scholar Back to article
Chia SE, Tan CS, Lim GH, Sim X, Lau W and Chia KS. Incidence, mortality and five-year relative survival ratio of prostate cancer among Chinese residents in Singapore from 1968 to 2002 by metastatic staging. Annals Academy of Medicine Singapore. 2010; 39(6): 466–471.
Search in Google Scholar Back to article
Sankaranarayanan R, Swaminathan R, Jayant K and Brenner H. An overview of cancer survival in Africa, Asia, the Caribbean and Central America: The case for investment in cancer health services. IARC Sci Publ. 2011; 162: 257–291.
Search in Google Scholar Back to article
Maringe C, Li R, Mangtani P, Coleman MP and Rachet B. Cancer survival differences between South Asians and non-South Asians of England in 1986–2004, accounting for age at diagnosis and deprivation. Br J Cancer. 2015; 113(1): 173–181. DOI: 10.1038/bjc.2015.182
Open DOI Search in Google Scholar Back to article
Taitt HE. Global trends and prostate cancer: A review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health. 2018; 12(6): 1807–1823. DOI: 10.1177/1557988318798279
Open DOI Search in Google Scholar Back to article
Kimura T. East meets West: Ethnic differences in prostate cancer epidemiology between East Asians and Caucasians. Chin J Cancer. 2012; 31(9): 421–429. DOI: 10.5732/cjc.011.10324
Open DOI Search in Google Scholar Back to article
Cuzick J, Thorat MA, Andriole G, et al. Prevention and early detection of prostate cancer. Lancet Oncol. 2014; 15(11): e484–492. DOI: 10.1016/S1470-2045(14)70211-6
Open DOI Search in Google Scholar Back to article
Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008; 9(8): 730–756. DOI: 10.1016/S1470-2045(08)70179-7
Open DOI Search in Google Scholar Back to article
Bekelman JE, Rumble RB, Chen RC, et al. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline. J Clin Oncol. 2018; 36(32): JCO1800606. DOI: 10.1200/JCO.18.00606
Open DOI Search in Google Scholar Back to article
Steele CB, Li J, Huang B and Weir HK. Prostate cancer survival in the United States by race and stage (2001–2009): Findings from the CONCORD-2 study. Cancer. 2017; 123(Suppl 24): 5160–5177. DOI: 10.1002/cncr.31026
Open DOI Search in Google Scholar Back to article
Critz FA, Benton JB, Shrake P and Merlin ML. 25-Year disease-free survival rate after irradiation for prostate cancer calculated with the prostate specific antigen definition of recurrence used for radical prostatectomy. J Urol. 2013; 189(3): 878–883. DOI: 10.1016/j.juro.2012.10.061
Open DOI Search in Google Scholar Back to article

Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis

Abstract

Paradigm

My account